György Paragh
György Paragh
University of Debrecen, Medical and Health Science Centre
E-mail megerősítve itt:
Hivatkozott rá
Hivatkozott rá
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
AFG Cicero, A Colletti, G Bajraktari, O Descamps, DM Djuric, M Ezhov, ...
Nutrition reviews 75 (9), 731-767, 2017
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
G Kerekes, Z Szekanecz, H Dér, Z Sándor, G Lakos, L Muszbek, I Csipö, ...
The Journal of rheumatology 35 (3), 398-406, 2008
Study of factors influencing the decreased HDL associated PON1 activity with aging
I Seres, G Paragh, E Deschene, T Fulop Jr, A Khalil
Experimental gerontology 39 (1), 59-66, 2004
Angiogenesis in rheumatoid arthritis
Z Szekanecz, T Besenyei, G Paragh, AE Koch
Autoimmunity 42 (7), 563-573, 2009
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
G Paragh, P Balla, E Katona, I Seres, A Égerházi, I Degrell
European archives of psychiatry and clinical neuroscience 252 (2), 63-67, 2002
The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia
G Paragh, I Seres, Z Balogh, Z Varga, I Kárpáti, J Mátyus, L Újhelyi, ...
Nephron 80 (2), 166-170, 1998
Rheumatoid arthritis and metabolic syndrome
G Kerekes, MT Nurmohamed, MA González-Gay, I Seres, G Paragh, ...
Nature Reviews Rheumatology 10 (11), 691, 2014
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial
DR Illingworth, JR Crouse III, DB Hunninghake, MH Davidson, ID Escobar, ...
Current medical research and opinion 17 (1), 43-50, 2001
Serum paraoxonase activity changes in uremic and kidney-transplanted patients
G Paragh, L Asztalos, I Seres, Z Balogh, L Löcsey, I Kárpáti, J Mátyus, ...
Nephron 83 (2), 126-131, 1999
Assessment of subclinical vascular disease associated with ankylosing spondylitis
N Bodnár, G Kerekes, I Seres, G Paragh, J Kappelmayer, ZG Némethné, ...
The Journal of rheumatology 38 (4), 723-729, 2011
New insights in synovial angiogenesis
Z Szekanecz, T Besenyei, G Paragh, AE Koch
Joint Bone Spine 77 (1), 13-19, 2010
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage
M Harangi, I Seres, Z Varga, G Emri, Z Szilvássy, G Paragh, É Remenyik
European journal of clinical pharmacology 60 (10), 685-691, 2004
The role of nutraceuticals in statin intolerant patients
M Banach, AM Patti, RV Giglio, AFG Cicero, AG Atanasov, G Bajraktari, ...
Journal of the American College of Cardiology 72 (1), 96-118, 2018
Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-κB activation and oxidative stress
Z Derdák, P Fülöp, E Sabo, R Tavares, EP Berthiaume, MB Resnick, ...
Carcinogenesis 27 (5), 956-961, 2006
Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
Z Balogh, I Seres, M Harangi, P Kovacs, GY Kakuk, GY Paragh
Elsevier Masson, 2008
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS …
AJ Vallejo-Vaz, A Akram, SRK Seshasai, D Cole, GF Watts, GK Hovingh, ...
Atherosclerosis Supplements 22, 1-32, 2016
Age related variations of some polymorphonuclear leukocyte functions
T Fülöp Jr, G Fóris, I Wórum, G Paragh, A Leövey
Mechanisms of ageing and development 29 (1), 1-8, 1985
The effect of atorvastatin therapy on lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase
A Kassai, L Illyés, HZ Mirdamadi, I Seres, T Kalmár, M Audikovszky, ...
Clinical biochemistry 40 (1-2), 1-5, 2007
Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus
E Kiss, I Seres, T Tarr, Z Kocsis, G Szegedi, G PARAGH
Annals of the New York Academy of Sciences 1108 (1), 83-91, 2007
Lack of UCP2 reduces fas‐mediated liver injury in ob/ob mice and reveals importance of cell‐specific UCP2 expression
P Fülöp, Z Derdák, A Sheets, E Sabo, EP Berthiaume, MB Resnick, ...
Hepatology 44 (3), 592-601, 2006
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20